EGFR mutations and molecularly targeted therapy:: a new era in the treatment of lung cancer

被引：15
|
作者：
Dowell, JE
Minna, JD
机构：
[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA
[2] Dallas VA Med Ctr, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Ctr Canc Genet, Dallas, TX USA
[4] Univ Texas, SW Med Ctr, NCI Special Program Res Excellence, Dallas, TX USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 04期
关键词：
D O I：
10.1038/ncponc0476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：170 / 171
页数：2
相关论文
共 50 条
  • [1] EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer
    Jonathan E Dowell
    John D Minna
    Nature Clinical Practice Oncology, 2006, 3 : 170 - 171
  • [2] Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors
    Haber, D. A.
    Bell, D. W.
    Sordella, R.
    Kwak, E. L.
    Godin-Heymann, N.
    Sharma, S. V.
    Lynch, T. J.
    Settleman, J.
    Molecular Approaches to Controlling Cancer, 2005, 70 : 419 - 426
  • [3] EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy
    Noronha, Vanita
    Prabhash, Kumar
    Thavamani, Abhishek
    Chougule, Anuradha
    Purandare, Nilendu
    Joshi, Amit
    Sharma, Rashmi
    Desai, Saral
    Jambekar, Nirmala
    Dutt, Amit
    Mulherkar, Rita
    PLOS ONE, 2013, 8 (04):
  • [4] Targeted therapy in small cell lung cancer: A new era?
    Capelletto, Enrica
    Mariniello, Annapaola
    Novello, Silvia
    LUNG CANCER, 2017, 108 : 252 - 253
  • [5] New molecularly targeted therapies for lung cancer
    Sun, Sophie
    Schiller, Joan H.
    Spinola, Monica
    Minna, John D.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10): : 2740 - 2750
  • [6] Combination therapy with molecularly targeted agents in lung cancer
    Okamoto, Isamu
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Advances in the treatment of thyroid cancer in the era of molecularly targeted therapies
    Malouf, G.
    Baudin, E.
    Soria, J. -C.
    Schlumberger, M.
    BULLETIN DU CANCER, 2009, 96 (01) : 95 - 101
  • [8] EGFR mutations and lung cancer: the era of precision medicine in oncology
    Sekerus, V.
    Andrijevic, L.
    Lazin, S.
    Potic, M.
    Vuckovic, D.
    Lovrenski, A.
    Tegeltija, D.
    Andrijevic, I.
    FEBS OPEN BIO, 2022, 12 : 87 - 88
  • [9] Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
    Jin, Jing
    Wu, Xu
    Yin, Jianhua
    Li, Mingxing
    Shen, Jing
    Li, Jing
    Zhao, Yueshui
    Zhao, Qijie
    Wu, Jingbo
    Wen, Qinglian
    Cho, Chi Hin
    Yi, Tao
    Xiao, Zhangang
    Qu, Liping
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer
    Wang, Xian-Bao
    Zhou, Hai-Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 123 - 128
12345